Socioeconomic status as a moderator of ADHD treatment outcomes.

PubWeight™: 1.23‹?› | Rank: Top 10%

🔗 View Article (PMID 11886021)

Published in J Am Acad Child Adolesc Psychiatry on March 01, 2002

Authors

Ricardo Rieppi1, Laurence L Greenhill, Rebecca E Ford, Shirley Chuang, Min Wu, Mark Davies, Howard B Abikoff, L Eugene Arnold, C Keith Conners, Glen R Elliott, Lily Hechtman, Stephen P Hinshaw, Betsy Hoza, Peter S Jensen, Helena C Kraemer, John S March, Jeffrey H Newcorn, William E Pelham, Joanne B Severe, James M Swanson, Benedetto Vitiello, Karen C Wells, Timothy Wigal

Author Affiliations

1: Department of Psychology, St. Johns University, Jamaica, NY 11439, USA. rriep477@stjohns.edu

Articles citing this

Enhancements to the behavioral parent training paradigm for families of children with ADHD: review and future directions. Clin Child Fam Psychol Rev (2004) 1.75

Evidence-based psychosocial treatments for children and adolescents with attention-deficit/hyperactivity disorder. J Clin Child Adolesc Psychol (2013) 1.60

Predictors and moderators of treatment outcome in the Pediatric Obsessive Compulsive Treatment Study (POTS I). J Am Acad Child Adolesc Psychiatry (2010) 1.42

Development and initial testing of a new socioeconomic status measure based on housing data. J Urban Health (2011) 1.27

Nine months of multicomponent behavioral treatment for ADHD and effectiveness of MTA fading procedures. J Abnorm Child Psychol (2004) 1.03

Application of a novel socioeconomic measure using individual housing data in asthma research: an exploratory study. NPJ Prim Care Respir Med (2014) 0.89

Individual differences in attention deficit hyperactivity disorder symptoms and associated executive dysfunction and traits: sex, ethnicity, and family income. Am J Orthopsychiatry (2013) 0.89

Deficits in diagnosis, treatment and continuity of care in African-American children and adolescents with ADHD. J Natl Med Assoc (2006) 0.83

Seeing the destination but not the path: Effects of socioeconomic disadvantage on school-focused possible self content and linked behavioral strategies. Self Identity (2011) 0.82

The severely impaired do profit most: short-term and long-term predictors of therapeutic change for a parent management training under routine care conditions for children with externalizing problem behavior. Eur Child Adolesc Psychiatry (2009) 0.80

Pediatric Asthma and Problems in Attention, Concentration, and Impulsivity: Disruption of the Family Management System. Fam Syst Health (2008) 0.79

Psychosocial Interventions to Improve the School Performance of Students with Attention-Deficit/Hyperactivity Disorder. Mind Brain (2010) 0.79

The Influence of Comorbid Depression and Conduct Disorder on MET/CBT Treatment Outcome for Adolescent Substance Use Disorders. Int J Cogn Ther (2013) 0.78

Ethnicity as a moderator of treatment effects on parent--child interaction for children with ADHD. J Atten Disord (2009) 0.77

Comorbid symptomatology moderates response to risperidone, stimulant, and parent training in children with severe aggression, disruptive behavior disorder, and attention-deficit/hyperactivity disorder. J Child Adolesc Psychopharmacol (2015) 0.77

Assessing health disparities in children using a modified housing-related socioeconomic status measure: a cross-sectional study. BMJ Open (2016) 0.75

Increasing Understanding in Children of Depressed Parents: Predictors and Moderators of Intervention Response. Depress Res Treat (2015) 0.75

Impact of Mental Health Comorbidities on the Community-Based Pediatric Treatment and Outcomes of Children with Attention Deficit Hyperactivity Disorder. J Dev Behav Pediatr (2016) 0.75

Qualitative Treatment-Subgroup Interactions in a Randomized Clinical Trial of Treatments for Adolescents with ADHD: Exploring What Cognitive-Behavioral Treatment Works for Whom. PLoS One (2016) 0.75

The effects of instructions on mothers' ratings of child attention-deficit/hyperactivity disorder symptoms. J Abnorm Child Psychol (2011) 0.75

Articles by these authors

Fluoxetine, cognitive-behavioral therapy, and their combination for adolescents with depression: Treatment for Adolescents With Depression Study (TADS) randomized controlled trial. JAMA (2004) 15.34

ChEMBL: a large-scale bioactivity database for drug discovery. Nucleic Acids Res (2011) 14.51

Fission and selective fusion govern mitochondrial segregation and elimination by autophagy. EMBO J (2008) 12.89

The prevalence and correlates of adult ADHD in the United States: results from the National Comorbidity Survey Replication. Am J Psychiatry (2006) 11.85

Efficacy and safety of immediate-release methylphenidate treatment for preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry (2006) 11.25

Comparison of the Atkins, Zone, Ornish, and LEARN diets for change in weight and related risk factors among overweight premenopausal women: the A TO Z Weight Loss Study: a randomized trial. JAMA (2007) 10.99

Cognitive behavioral therapy, sertraline, or a combination in childhood anxiety. N Engl J Med (2008) 10.48

Safety and tolerability of methylphenidate in preschool children with ADHD. J Am Acad Child Adolesc Psychiatry (2006) 10.19

Rationale, design, and methods of the Preschool ADHD Treatment Study (PATS). J Am Acad Child Adolesc Psychiatry (2006) 10.00

Stimulant-related reductions of growth rates in the PATS. J Am Acad Child Adolesc Psychiatry (2006) 9.98

Pharmacogenetics of methylphenidate response in preschoolers with ADHD. J Am Acad Child Adolesc Psychiatry (2006) 9.85

Risperidone in children with autism and serious behavioral problems. N Engl J Med (2002) 9.35

Reconstruction of functionally normal and malignant human breast tissues in mice. Proc Natl Acad Sci U S A (2004) 7.96

The MTA at 8 years: prospective follow-up of children treated for combined-type ADHD in a multisite study. J Am Acad Child Adolesc Psychiatry (2009) 6.71

Columbia Classification Algorithm of Suicide Assessment (C-CASA): classification of suicidal events in the FDA's pediatric suicidal risk analysis of antidepressants. Am J Psychiatry (2007) 6.35

The ChEMBL bioactivity database: an update. Nucleic Acids Res (2013) 5.41

Switching to another SSRI or to venlafaxine with or without cognitive behavioral therapy for adolescents with SSRI-resistant depression: the TORDIA randomized controlled trial. JAMA (2008) 4.91

Untreated depression and hippocampal volume loss. Am J Psychiatry (2003) 4.84

The Texas Children's Medication Algorithm Project: revision of the algorithm for pharmacotherapy of attention-deficit/hyperactivity disorder. J Am Acad Child Adolesc Psychiatry (2006) 4.58

Practice parameter for the use of stimulant medications in the treatment of children, adolescents, and adults. J Am Acad Child Adolesc Psychiatry (2002) 4.57

Risk factors for childhood overweight: a prospective study from birth to 9.5 years. J Pediatr (2004) 4.38

The role and interpretation of pilot studies in clinical research. J Psychiatr Res (2010) 3.89

Childhood predictors of adolescent substance use in a longitudinal study of children with ADHD. J Abnorm Psychol (2003) 3.86

Report by the ACNP Task Force on response and remission in major depressive disorder. Neuropsychopharmacology (2006) 3.80

The Treatment for Adolescents With Depression Study (TADS): long-term effectiveness and safety outcomes. Arch Gen Psychiatry (2007) 3.78

Evaluating dopamine reward pathway in ADHD: clinical implications. JAMA (2009) 3.69

DSM-5 field trials in the United States and Canada, Part II: test-retest reliability of selected categorical diagnoses. Am J Psychiatry (2013) 3.58

Tympanostomy tubes and developmental outcomes at 9 to 11 years of age. N Engl J Med (2007) 3.52

CUL4-DDB1 ubiquitin ligase interacts with multiple WD40-repeat proteins and regulates histone methylation. Nat Cell Biol (2006) 3.49

Geographic variation in the prevalence of attention-deficit/hyperactivity disorder: the sunny perspective. Biol Psychiatry (2013) 3.47

A practical measure of impairment: psychometric properties of the impairment rating scale in samples of children with attention deficit hyperactivity disorder and two school-based samples. J Clin Child Adolesc Psychol (2006) 3.46

Evaluating iatrogenic risk of youth suicide screening programs: a randomized controlled trial. JAMA (2005) 3.46

Coming to terms with risk factors for eating disorders: application of risk terminology and suggestions for a general taxonomy. Psychol Bull (2004) 3.39

3-year follow-up of the NIMH MTA study. J Am Acad Child Adolesc Psychiatry (2007) 3.33

Instability of the DSM-IV Subtypes of ADHD from preschool through elementary school. Arch Gen Psychiatry (2005) 3.30

Double-blind comparison of first- and second-generation antipsychotics in early-onset schizophrenia and schizo-affective disorder: findings from the treatment of early-onset schizophrenia spectrum disorders (TEOSS) study. Am J Psychiatry (2008) 3.30

Global analysis of H3K4 methylation defines MLL family member targets and points to a role for MLL1-mediated H3K4 methylation in the regulation of transcriptional initiation by RNA polymerase II. Mol Cell Biol (2009) 3.26

Epidemiology and correlates of daily smoking and nicotine dependence among young adults in the United States. Am J Public Health (2005) 3.18

Predictors of spontaneous and systematically assessed suicidal adverse events in the treatment of SSRI-resistant depression in adolescents (TORDIA) study. Am J Psychiatry (2009) 3.17

Dopamine in drug abuse and addiction: results of imaging studies and treatment implications. Arch Neurol (2007) 3.11

Variables that affect the clinical use and abuse of methylphenidate in the treatment of ADHD. Am J Psychiatry (2003) 3.10

National trends in the treatment of attention deficit hyperactivity disorder. Am J Psychiatry (2003) 3.07

Functional interrogation of the kinome using nucleotide acyl phosphates. Biochemistry (2007) 3.01

Predictors and moderators of acute outcome in the Treatment for Adolescents with Depression Study (TADS). J Am Acad Child Adolesc Psychiatry (2006) 2.95

Risperidone for the core symptom domains of autism: results from the study by the autism network of the research units on pediatric psychopharmacology. Am J Psychiatry (2005) 2.94

Development and natural history of mood disorders. Biol Psychiatry (2002) 2.90

Patterns and predictors of attention-deficit/hyperactivity disorder persistence into adulthood: results from the national comorbidity survey replication. Biol Psychiatry (2005) 2.87

Lithium treatment moderate-dose use study (LiTMUS) for bipolar disorder: a randomized comparative effectiveness trial of optimized personalized treatment with and without lithium. Am J Psychiatry (2013) 2.80

GOLPH3 modulates mTOR signalling and rapamycin sensitivity in cancer. Nature (2009) 2.77

Cognitive-behavioral psychotherapy for anxiety and depressive disorders in children and adolescents: an evidence-based medicine review. J Am Acad Child Adolesc Psychiatry (2004) 2.75

A prospective study of 80,000 total joint and 5000 anterior cruciate ligament reconstruction procedures in a community-based registry in the United States. J Bone Joint Surg Am (2010) 2.66

Treatment of selective serotonin reuptake inhibitor-resistant depression in adolescents: predictors and moderators of treatment response. J Am Acad Child Adolesc Psychiatry (2009) 2.65

Exosomes mediate the cell-to-cell transmission of IFN-α-induced antiviral activity. Nat Immunol (2013) 2.64

The prognostic value of end tidal carbon dioxide during cardiac arrest: a systematic review. Resuscitation (2013) 2.59

Giving control to patients. Br J Gen Pract (2008) 2.56

Suicide attempts and nonsuicidal self-injury in the treatment of resistant depression in adolescents: findings from the TORDIA study. J Am Acad Child Adolesc Psychiatry (2011) 2.55